1
results found
Introduction Triple-negative breast cancer (TNBC) is an aggressive subtype characterized by poor prognosis. Based on the KEYNOTE-522 trial, neoadjuvant pembrolizumab plus chemotherapy has become the s...
tumor-infiltrating lymphocytes
triple-negative breast cancer
neoadjuvant therapy
immunotherapy
pathological complete response
SinoXiv